bioAffinity Technologies, Inc. BIAFW
0.15 USD -0.07 (-31.55%)
Nov 12, 2026, 11:34 AM EST
0.1506 Day range 0.1506
0.1506 52-week range 0.1506
- YTD
- 0.00%
- 1 year
- 0.00%
Financial health
Altman Z-Score
-18.82 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
Rating
B-2 / 5 overall
- DCF 4
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 2
- P/E 1
- P/B 5
Valuation
P/E -0.1×
FY 2019 5y median -1.2× FY 2025
P/S 0.3×
FY 2019 5y median 1.2× FY 2025
P/B 0.3×
FY 2019 5y median 0.7× FY 2025
P/FCF -0.2×
FY 2019 5y median -1.7× FY 2025
EV/EBITDA 0.2×
FY 2019 5y median -1.4× FY 2025
EV/Sales -0.5×
FY 2019 5y median 0.0× FY 2025
FCF Yield -462.3%
FY 2019 5y median -59.6% FY 2025
Profitability
Gross Margin 23.2%
FY 2019 5y median 31.3% FY 2025
Operating Margin -171.6%
FY 2019 5y median -171.6% FY 2025
Net Margin -242.0%
FY 2019 5y median -242.0% FY 2025
ROE -204.9%
FY 2019 5y median -163.5% FY 2025
ROIC -125.3%
FY 2019 5y median -123.9% FY 2025
ROA -136.0%
FY 2019 5y median -136.0% FY 2025
Growth (YoY)
Revenue -34.2%
FY 2019 FY 2025
Operating Income -18.1%
FY 2019 FY 2025
EPS (diluted) 61.5%
FY 2019 FY 2025
Free Cash Flow -27.9%
FY 2019 FY 2025
Financial Health
Current Ratio 2.6×
FY 2019 5y median 1.8× FY 2025
Quick Ratio 2.6×
FY 2019 5y median 1.8× FY 2025
Debt / Equity 0.2×
FY 2019 5y median 0.2× FY 2025
Net Debt / EBITDA 0.4×
FY 2019 5y median 0.2× FY 2025
Interest Coverage -238×
FY 2019 5y median -96.8× FY 2025
Dividends
Dividend Yield 0.0%
FY 2019 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2019 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31